COVID
Clinical trials for COVID explained in plain language.
Never miss a new study
Get alerted when new COVID trials appear
Sign up with your email to follow new studies for COVID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a One-Time antibody infusion stop COVID-19 from getting worse?
Disease control Recruiting nowThis study tests whether a single infusion of concentrated antibodies against COVID-19 can help adults with early, mild COVID-19 recover faster and avoid serious illness. About 820 participants at higher risk (age 55+ or with weakened immune systems) will receive either the antib…
Matched conditions: COVID
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
New nose swab test aims to spot coronaviruses faster
Diagnosis Recruiting nowThis study evaluates a new test called the BioFire Emerging Coronavirus Panel, which uses leftover nose swab samples to detect coronaviruses, including COVID-19. Researchers will check how accurate and reliable the test is compared to standard methods. About 1,500 samples will be…
Matched conditions: COVID
Sponsor: BioFire Defense LLC • Aim: Diagnosis
Last updated May 17, 2026 02:24 UTC
-
New at-home COVID test aims to make virus detection easier and faster
Diagnosis Recruiting nowThis study checks if a new COVID-19 test, called Metrix COVID Test, works well when used at home or in clinics. About 1000 people with COVID-like symptoms will take the test, and results will be compared to a standard FDA-cleared test. The goal is to see if the new test accuratel…
Matched conditions: COVID
Phase: NA • Sponsor: Aptitude Medical Systems • Aim: Diagnosis
Last updated May 13, 2026 15:58 UTC
-
AI could revolutionize how cancer patients find clinical trials
Knowledge-focused Recruiting nowThis study is testing whether an artificial intelligence (AI) tool can help match people with advanced cancer to the right clinical trials. Researchers will enroll up to 50,000 participants to see if the AI improves trial enrollment rates and patient outcomes. The goal is to make…
Matched conditions: COVID
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC